SBC Medical Group
SBC | NASDAQ
$5.14
+$0.39 (+8.21%)
At close: Sep 21, 2026, 4:00 PM ET
$5.24
+$0.10 (+1.95%)
Pre-market:
Sep 22, 2026, 4:43 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Net Income | 50.99M | 46.61M | 39.37M | 5.55M |
Depreciation & Amortization | 2.68M | 3.8M | 12.25M | 5.93M |
Stock-Based Compensation | n/a | 13.02M | n/a | n/a |
Other Working Capital | -19.24M | -17.45M | -12.04M | -493.08K |
Other Non-Cash Items | -7.79M | -16.31M | 2.59M | 2.96M |
Deferred Income Tax | 5.33M | -14.42M | 4.11M | -3.9M |
Change in Working Capital | -12.28M | -12.13M | -7.68M | -10.59M |
Operating Cash Flow | 38.92M | 20.58M | 50.64M | -47.37K |
Capital Expenditures | -2.37M | -3.41M | -11.21M | -24.95M |
Cash Acquisitions | -15.46M | -5.07M | 722.55K | -6.49M |
Purchase of Investments | -21.05M | -331.5K | -2.11M | -2.65M |
Sales Maturities Of Investments | n/a | n/a | 4.13M | n/a |
Other Investing Acitivies | 18.34M | -1.29M | 8.6M | 1.43M |
Investing Cash Flow | -20.97M | -10.1M | 1.82M | -32.65M |
Debt Repayment | 18.83M | 6.48M | 3.58M | -5.08M |
Common Stock Repurchased | -5M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 10.21M | 16.45M | 2.56M | -121.72M |
Financial Cash Flow | 24.04M | 22.97M | 6.14M | -7.98M |
Net Cash Flow | 38.73M | 22.02M | 51.28M | -52.77M |
Free Cash Flow | 36.55M | 17.17M | 39.44M | -24.99M |
Adj. Free Cash Flow | 36.55M | 4.15M | 39.44M | -24.99M |
Maintenance CapEx | -2.37M | -2.27M | -9.05M | -24.95M |
Growth CapEx | n/a | -1.14M | -2.16M | n/a |
Owner Earnings | 36.55M | 18.31M | 41.6M | -24.99M |
Add to Watchlist
Select watchlists to add or remove SBC